【人类胚胎基因编辑的伦理边界】英文范文详解

The prospect of employing gene-editing technologies, such as CRISPR-Cas9, to modify the human germline presents a profound ethical dilemma that necessitates a delicate equilibrium between unprecedented therapeutic potential and fundamental moral responsibility. Advocates maintain that precise genomic correction could irrevocably eradicate severe hereditary disorders, thereby alleviating generational suffering and substantially curtailing the long-term strain on public healthcare infrastructures. Conversely, bioethicists warn that unchecked intervention into embryonic development might precipitate unforeseen off-target mutations and inadvertently normalize eugenic selection, which would fundamentally undermine human genetic diversity and exacerbate socio-economic disparities. Accordingly, a stringent regulatory framework that rigorously confines clinical applications to monogenic life-threatening conditions, while mandating transparent global oversight and longitudinal safety assessments, remains indispensable for harnessing this transformative technology responsibly.

使用CRISPR-Cas9等基因编辑技术修改人类生殖系的前景提出了一个深刻的伦理困境，需要在前所未有的治疗潜力与根本的道德责任之间寻求微妙的平衡。支持者坚持认为，精确的基因组校正能够不可逆转地根除严重的遗传疾病，从而减轻代际痛苦，并大幅缓解公共卫生基础设施的长期压力。相反，生物伦理学家警告称，不受约束的胚胎发育干预可能会引发不可预见的脱靶突变，并无意中使优生选择合法化，这将从根本上破坏人类基因多样性并加剧社会经济不平等。因此，一个严格的监管框架对于负责任地驾驭这项变革性技术不可或缺，该框架将临床应用严格限定于单基因危及生命的疾病，同时要求实施透明的全球监督与纵向安全评估。